Genentech sees more potential in peptides, signs $1B biobucks deal with PeptiDream

PeptiDream is clearly doing something right. Big Pharmas have been queueing round the block to collaborate on the Japanese biotech’s peptide discovery platform, and, now, long-term partner Genentech is back with $40 million in upfront cash for a fresh licensing agreement.